In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Jazwares, a toy company owned by Warren Buffett's Berkshire Hathaway , recalled about 125,000 "America's Got Talent" microphones because they contain lithium-ion batteries that can overcharge and ...

Wall Street is coming off a losing session after the Federal Reserve paused its interest rate-cutting campaign, leaving its ...

Ford (NYSE: F) stock fell 5.5% after the auto giant forecast weaker annual profit at a time when the threat of US tariffs on ...

Find insight on BCE, Siemens Healthineers, WeChat, Apple, U.S. tariffs and more in the latest Market Talks covering ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

The FDA approved Zepbound for sleep apnea on Dec. 20. In this country, the organization that sets the tone for public coverage of medications is called Canada’s Drug Agency, formerly the ...

The United States Food and Drug Administration approved a similar drug, tirzepatide, sold as Zepbound ... for cash-strapped public drug plans in Canada, which have so far limited coverage of ...